Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac mapping. It also offers fibrillation, ventricular tachycardia, atrial flutter, simple arrhythmias and fluoro reduction solutions. Biosense Webster provides onsite training, offsite workshops, online training, EP training and professional and medical education services. The company offers training and online courses through its education centers in the US, Germany, Belgium, Sweden and Spain. Biosense Webster is headquartered in Diamond Bar, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biosense Webster Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Biosense Webster Inc Company Overview
- Biosense Webster Inc Company Snapshot
- Biosense Webster Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biosense Webster Inc - Pipeline Analysis Overview
- Biosense Webster Inc - Key Facts
- Biosense Webster Inc - Major Products and Services
- Biosense Webster Inc Pipeline Products by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc Pipeline Products Overview
- 3D Ultrasound Next Generation Catheter
- 3D Ultrasound Next Generation Catheter Product Overview
- CARTO 4
- CARTO 4 Product Overview
- CARTO SMARTTOUCH 5D Catheter
- CARTO SMARTTOUCH 5D Catheter Product Overview
- CARTO SMARTTOUCH 5D Catheter Clinical Trial
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter Product Overview
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter Clinical Trial
- Navigation Guided Deflectable Sheath
- Navigation Guided Deflectable Sheath Product Overview
- Omnypulse Bi-Directional Catheter
- Omnypulse Bi-Directional Catheter Product Overview
- Omnypulse Bi-Directional Catheter Clinical Trial
- Thermocool Smarttouch SF Dual Energy Catheter
- Thermocool Smarttouch SF Dual Energy Catheter Product Overview
- THERMOCOOL SMARTTOUCH SF-5D Catheter
- Product Status
- TRUPULSE Generator
- TRUPULSE Generator Product Overview
- TRUPULSE Generator Clinical Trial
- VARIPULSE Catheter
- VARIPULSE Catheter Product Overview
- VARIPULSE Catheter Clinical Trial
- Biosense Webster Inc - Key Competitors
- Biosense Webster Inc - Key Employees
- Biosense Webster Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biosense Webster Inc, Recent Developments
- Sep 22, 2023: Biosense Webster Receives 510(k) Clearance for CARTO 3 EP Navigation System Software V8.0
- Sep 18, 2023: Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe
- Aug 07, 2023: FDA approves J&J’s Afib ablation devices for use without fluoroscopy
- Jul 25, 2023: Biosense Webster introduces new OPTRELL mapping catheter in US
- Jul 21, 2023: Biosense Webster Receives Additional FDA 510(K) Clearance for CARTO VIZIGO Bi-Directional Guiding Sheath
- Jul 21, 2023: Biosense Webster Receives Additional FDA 510(K) Clearance for Webster CS Catheter
- Jul 21, 2023: Biosense Webster Receives Additional FDA 510(K) Clearance for PENTARAY Nav High-Density Mapping Catheter
- Jul 21, 2023: Biosense Webster Receives FDA 510(K) Clearance for DECANAV Mapping Catheter
- Jul 19, 2023: Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe
- May 19, 2023: Biosense Webster showcases award-winning real-world evidence demonstrating value of catheter ablation in driving improved patient outcomes in AFib at Heart Rhythm 2023
- Appendix
- Methodology
- About the Publisher
- Contact Us
- Disclaimer
- Biosense Webster Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biosense Webster Inc Pipeline Products by Equipment Type
- Biosense Webster Inc Pipeline Products by Indication
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc, Key Facts
- Biosense Webster Inc, Major Products and Services
- Biosense Webster Inc Number of Pipeline Products by Development Stage
- Biosense Webster Inc Pipeline Products Summary by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc Ongoing Clinical Trials Summary
- 3D Ultrasound Next Generation Catheter - Product Status
- 3D Ultrasound Next Generation Catheter - Product Description
- CARTO 4 - Product Status
- CARTO 4 - Product Description
- CARTO SMARTTOUCH 5D Catheter - Product Status
- CARTO SMARTTOUCH 5D Catheter - Product Description
- CARTO SMARTTOUCH 5D Catheter - Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Status
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Description
- Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
- Navigation Guided Deflectable Sheath - Product Status
- Navigation Guided Deflectable Sheath - Product Description
- Omnypulse Bi-Directional Catheter - Product Status
- Omnypulse Bi-Directional Catheter - Product Description
- Omnypulse Bi-Directional Catheter - Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Thermocool Smarttouch SF Dual Energy Catheter - Product Status
- Thermocool Smarttouch SF Dual Energy Catheter - Product Description
- Product Status
- THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Description
- TRUPULSE Generator - Product Status
- TRUPULSE Generator - Product Description
- TRUPULSE Generator - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
- TRUPULSE Generator - Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
- TRUPULSE Generator - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
- VARIPULSE Catheter - Product Status
- VARIPULSE Catheter - Product Description
- VARIPULSE Catheter - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
- VARIPULSE Catheter - Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
- Biosense Webster Inc, Key Employees
- Biosense Webster Inc, Subsidiaries
- Glossary
- Biosense Webster Inc Pipeline Products by Equipment Type
- Biosense Webster Inc Pipeline Products by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cook Medical Inc
- Boston Scientific Corp
- Biomerica Inc
- DFine Inc
- Cortech Solutions Inc
